ICU Medical, Inc. (ICUI)

Last Price: 198.52 (2020-09-18)

Company Description

ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. They are one of the world's leading pure-play infusion therapy companies, with global operations and a wide-ranging product portfolio that includes IV solutions, IV smart pumps, dedicated and non-dedicated IV sets and needlefree connectors, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. In addition, they manufacture automated pharmacy IV compounding systems with workflow technology, closed systems transfer devices for hazardous IV drugs, and cardiac monitoring systems to optimize patient fluid levels.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $1.27B
Net Income (Most Recent Fiscal Year) $101.04M
PE Ratio (Current Year Earnings Estimate) 35.86
PE Ratio (Trailing 12 Months) 31.17
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) 3.25
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 2.88
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) 16.52
Pre-Tax Margin (Trailing 12 Months) 7.56%
Net Margin (Trailing 12 Months) 6.61%
Return on Equity (Trailing 12 Months) 9.77%
Return on Assets (Trailing 12 Months) 7.68%
Current Ratio (Most Recent Fiscal Quarter) 2.89
Quick Ratio (Most Recent Fiscal Quarter) 1.99
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 2.42
Book Value per Share (Most Recent Fiscal Quarter) $66.62
Earnings per Share (Most Recent Fiscal Quarter) $1.45
Earnings per Share (Most Recent Fiscal Year) $7.36
Diluted Earnings per Share (Trailing 12 Months) $3.86
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 20.94M
Free Float 18.66M
Market Capitalization $4.08B
Average Volume (Last 20 Days) 0.14M
Beta (Past 60 Months) 0.65
Percentage Held By Insiders (Latest Annual Proxy Report) 10.90%
Percentage Held By Institutions (Latest 13F Reports) 92.37%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%